Our current model (Fig. 6D) summarizes these data, which suggest that BMI1 promotes tumor cell growth by inhibiting LATS1/2 phosphorylation and allowing YAP/TAZ/TEAD to transcribe canonical target genes (such as AXL, CYR61, and CTGF). The gene discussed is CCN2; the disease is neoplasm.